In this Journal of Opioid Management op-ed, Center for U.S. Policy Senior Fellow Lynn Webster, M.D., and co-authors explain that state licensing boards and civil lawsuits, along with the federal government’s administrative framework, are more appropriate forums than federal criminal courts when dealing with questions surrounding medical care
Thirty-three not-for-profit organizations sent a letter to commend Members of Congress for introducing a bill to provide Medicare coverage and create a new Medicaid payment category for prescription digital therapies. The “Access to Prescription Digital Therapeutics Act of 2022” is sponsored by Sens. Jeanne Shaheen (NH) and Shelley Moore Capito (WV), and Reps. Mike Thompson (CA-5) and David McKinley (WV-01).
The Center for U.S. Policy, Aimed Alliance, and the International Health Facility Diversion Association commended the federal government for facilitating patient access to prescription digital behavioral therapies. “We thank CMS for acting with speed to expand access to evidence-based digital therapies for behavioral health.”
We commend @HHSGov’s awards to states, tribes of $1.5 billion to address #substanceusedisorder. Funding will promote #recovery by #IncreasingAccess to 24/7 treatment programs and removing barriers to medications for #opioidusedisorder. #RecoveryMonth https://www.whitehouse.gov/briefing-room/statements-releases/2022/09/24/what-they-are-reading-in-the-states-biden-harris-administration-awards-1-5-billion-to-states-and-tribes-to-combat-overdose-epidemic/
We support inclusivity and transparency in the administration and disbursement of #opioidlitigation proceeds. https://woub.org/2022/08/10/drug-policy-reform-group-sues-the-board-responsible-for-spending-half-of-ohios-opioid-settlement-money/
We are pleased to announce that our Chairman @MCBtweets will be special editor of the legal-legislative-regulatory issue of the Journal of Opioid Management.
Learn more here: https://www.wmpllc.org/ojs/index.php/jom/pages/view/Legal
